TIVDAK Trademark

Trademark Overview

On Tuesday, September 25, 2018, a trademark application was filed for TIVDAK with the United States Patent and Trademark Office. The USPTO has given the TIVDAK trademark a serial number of 88130645. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 5, 2022. This trademark is owned by Seattle Genetics, Inc.. The TIVDAK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
tivdak

General Information

Serial Number88130645
Word MarkTIVDAK
Filing DateTuesday, September 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2019

Trademark Statements

Goods and ServicesBiotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 2, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSEAGEN INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOTHELL, WA 98021
Party NameSeattle Genetics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBothell, WA 98021
Party NameSeattle Genetics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98021

Trademark Events

Event DateEvent Description
Monday, December 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, July 15, 2022ASSIGNED TO EXAMINER
Monday, May 2, 2022ASSIGNED TO EXAMINER
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 27, 2022SOU EXTENSION 5 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 5 FILED
Wednesday, April 20, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 20, 2021CORRECTED NOA E-MAILED
Tuesday, October 19, 2021DIVISIONAL PROCESSING COMPLETE
Monday, October 11, 2021DIVISIONAL REQUEST RECEIVED
Monday, October 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 11, 2021TEAS REQUEST TO DIVIDE RECEIVED
Thursday, October 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 5, 2021SOU EXTENSION 4 GRANTED
Tuesday, October 5, 2021SOU EXTENSION 4 FILED
Tuesday, October 5, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021SOU EXTENSION 3 GRANTED
Thursday, April 15, 2021SOU EXTENSION 3 FILED
Thursday, April 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, January 13, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 25, 2020SOU EXTENSION 2 GRANTED
Friday, September 25, 2020SOU EXTENSION 2 FILED
Friday, September 25, 2020SOU TEAS EXTENSION RECEIVED
Thursday, August 13, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 3, 2020SOU EXTENSION 1 GRANTED
Friday, April 3, 2020SOU EXTENSION 1 FILED
Friday, April 3, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 12, 2019ASSIGNED TO EXAMINER
Tuesday, October 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 14, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 31, 2019ASSIGNED TO LIE
Wednesday, July 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 8, 2019NON-FINAL ACTION E-MAILED
Tuesday, January 8, 2019NON-FINAL ACTION WRITTEN
Monday, January 7, 2019ASSIGNED TO EXAMINER
Tuesday, October 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 28, 2018NEW APPLICATION ENTERED

Related Keywords

tivdak system research preparations pharmaceutical disorders development prevention treatment diagnosis gastroenterological